Xilio Therapeutics Inc.

NASDAQ: XLO · Real-Time Price · USD
0.70
0.02 (3.20%)
At close: Jun 06, 2025, 3:59 PM
0.70
0.63%
After-hours: Jun 06, 2025, 05:11 PM EDT

Xilio Therapeutics Revenue

Xilio Therapeutics reported an annual revenue of $6.34M, reflecting a 0% growth. For the quarter ending March 31, 2025, Xilio Therapeutics generated $2.93M in revenue.
Revenue (ttm)
$6.34M
Revenue Growth
0%
Price / Sales Ratio
8.06
Revenue / Employee
$99.13K
Employees
64
Market Cap
36.25M

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.